173 related articles for article (PubMed ID: 7954350)
1. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.
Beck J; Niethammer D; Gekeler V
Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350
[TBL] [Abstract][Full Text] [Related]
2. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V
Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
[TBL] [Abstract][Full Text] [Related]
3. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
4. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias.
Beck J; Niethammer D; Gekeler V
Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
[TBL] [Abstract][Full Text] [Related]
7. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.
Beck J; Handgretinger R; Klingebiel T; Dopfer R; Schaich M; Ehninger G; Niethammer D; Gekeler V
Leukemia; 1996 Mar; 10(3):426-33. PubMed ID: 8642857
[TBL] [Abstract][Full Text] [Related]
8. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
9. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.
Burger H; Nooter K; Sonneveld P; Van Wingerden KE; Zaman GJ; Stoter G
Br J Haematol; 1994 Oct; 88(2):348-56. PubMed ID: 7803281
[TBL] [Abstract][Full Text] [Related]
10. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.
Beck J; Bohnet B; Brügger D; Bader P; Dietl J; Scheper RJ; Kandolf R; Liu C; Niethammer D; Gekeler V
Br J Cancer; 1998; 77(1):87-91. PubMed ID: 9459150
[TBL] [Abstract][Full Text] [Related]
11. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
12. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
14. A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues.
Schwarzenbach H
Anal Biochem; 2002 Sep; 308(1):26-33. PubMed ID: 12234460
[TBL] [Abstract][Full Text] [Related]
15. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
16. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.
Kim WJ; Kakehi Y; Kinoshita H; Arao S; Fukumoto M; Yoshida O
J Urol; 1996 Aug; 156(2 Pt 1):506-11. PubMed ID: 8683726
[TBL] [Abstract][Full Text] [Related]
19. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
Clifford SC; Neal DE; Lunec J
Br J Cancer; 1996 Mar; 73(5):659-66. PubMed ID: 8605104
[TBL] [Abstract][Full Text] [Related]
20. PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia.
Rochlitz CF; de Kant E; Neubauer A; Heide I; Böhmer R; Oertel J; Huhn D; Herrmann R
Ann Hematol; 1992 Dec; 65(6):241-6. PubMed ID: 1360821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
